非洲裔美国狼疮患者静脉血栓栓塞事件与抗磷脂抗体的关联:与白人患者的比较
多变量回归显示非洲裔美国患者具有临床显著aPL谱的可能性比白人患者低66%(95%CI 0.12-0.96;P=0.04)。VTE事件发生时非洲裔美国患者抗双链DNA水平更高(P=0.02)、血红蛋白更低(P=0.01)、红细胞沉降率更高(P=0.008)。结论提示非洲裔美国患者aPL阴性并不能降低VTE风险。
要点
- 非洲裔美国SLE合并VTE患者具有临床显著aPL谱的可能性比白人低66%。
- VTE事件时非洲裔美国患者抗dsDNA更高、血红蛋白更低、ESR更高。
- 非洲裔美国患者aPL阴性不意味着VTE风险降低。
核心结论
- 在SLE合并VTE事件的患者中,非洲裔美国患者比白人患者更少具有临床显著aPL谱。
- 非洲裔美国患者aPL谱阴性并不能降低其VTE风险。
研究设计与样本
- 回顾性研究,从学术医院的风湿病实践记录中检索白人及非洲裔美国SLE合并VTE事件患者。
- 临床显著aPL谱定义为抗心磷脂IgG/IgM和/或抗β2-糖蛋白I IgG/IgM≥40 units,和/或狼疮抗凝物阳性≥1.3。
- 采用逻辑回归确定临床显著aPL谱的预测因素。
主要发现
- 多变量回归中,非洲裔美国患者具有临床显著aPL谱的可能性比白人患者低66%(95%CI 0.12-0.96;P=0.04)。
- 三重阳性在白人患者中最常见,而8例非洲裔美国患者中有7例狼疮抗凝物检测阳性。
- VTE事件发生时,非洲裔美国患者抗双链DNA水平显著更高(P=0.02)、血红蛋白显著更低(P=0.01)、红细胞沉降率显著更高(P=0.008)。
关键数值与推荐
- 临床显著aPL谱:抗心磷脂IgG/IgM和/或抗β2-糖蛋白I IgG/IgM≥40 units,和/或狼疮抗凝物阳性≥1.3。
- SLE分类标准:ACR和/或2012年SLICC分类标准。
临床怎么用
- 对非洲裔美国SLE患者,即使aPL谱阴性,也应警惕VTE风险,不能因aPL阴性而降低对血栓事件的防范。
- VTE事件发生时非洲裔美国患者炎症指标(抗dsDNA、ESR)更高且贫血更明显,提示需综合评估炎症与血栓风险。
局限性
- 研究为回顾性设计,样本来自单一学术医院的风湿病实践,可能存在选择偏倚。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: The risk of thrombotic events is elevated in patients with systemic lupus erythematosus (SLE) compared to the general population and has been attributed to both systemic inflammation and to the presence of antiphospholipid antibodies (aPLs). Our objective was to examine differences in aPL prevalence in White and African American patients with SLE and venous thromboembolic (VTE) events, and to compare inflammatory markers at the time of a VTE event. METHODS: Records of White and African American patients with SLE and VTE events were retrieved from a rheumatology practice based at an academic hospital. A clinically significant aPL profile was defined as anti-cardiolipin IgG/IgM and/or anti-β2 -glycoprotein I IgG/IgM ≥40 units, and/or positive lupus anticoagulant ≥1.3. Logistic regression was used to determine predictors of a clinically significant aPL profile. RESULTS: Ninety-seven patients fulfilled American College of Rheumatology and/or 2012 Systemic Lupus Erythematosus International Collaborating Clinics classification criteria for SLE, had a history of VTE events, and had available aPL tests (59 White and 38 African American patients). African American patients were 66% less likely (95% confidence interval 0.12-0.96; P = 0.04) to have a clinically significant aPL profile compared to White patients in multivariable regression. Triple positivity was most frequent among White patients, while 7 of 8 African American patients had a positive lupus anticoagulant test. At the time of a VTE event, African American patients had significantly higher levels of anti-double-stranded DNA (P = 0.02), lower hemoglobin (P = 0.01), and higher erythrocyte sedimentation rate (P = 0.008). CONCLUSION: Among patients with SLE and VTE events, African American patients were less likely to have a clinically significant aPL profile compared to White patients, indicating that a negative aPL profile in African American patients does not decrease VTE risk.
引用
- Gkrouzman E, Peng M, Davis-Porada J, et al. Venous Thromboembolic Events in African American Lupus Patients in Association With Antiphospholipid Antibodies Compared to White Patients. Arthritis Care Res (Hoboken). 2022. PMID: 33171010. doi:10.1002/acr.24508
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。